. . . . "The component 50 provides a new form of ambulatory treatment for, e. .g., rheumatoid arthritis; or lung disease such as emphysema or asthma; or adult respiratory distress syndrome (ARDS); or auto immune disease; or AIDS. The component 50 serves to maintain a reduced population" . .